Leading The Revolution Sometimes the media (and perhaps the rest of us) needs and enjoys a good punch bag, and this week accompanied by her book “Ten Years To Save
Leading The Revolution Sometimes the media (and perhaps the rest of us) needs and enjoys a good punch bag, and this week accompanied by her book “Ten Years To Save
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Aukett, CleanTech,
Novacyt S.A. (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces changes to the Board of Directors.
NICE recommends the Genedrive® CYP2C19-ID Kit
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Argo Blockchain, Bluebird,
Paris, France, Eastleigh and Manchester, UK – 21 December 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces an update to the
Initial overseas orders of the Genedrive® MT-RNR1 ID Kit
The acquisition adds scale and diversification to create a stronger global diagnostics business, with a complementary suite of genomic technologies and services
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Amaroq, Belluscura, CleanTech, Critical
Golden Metal Resources (GMET), a mineral exploration company focused on tungsten, gold, copper and silver within Nevada, USA, published an Open Letter to Shareholders from the company’s Chairman outlining the progress
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Aminex, Aura, Bushveld,
RECOMMENDED CASH OFFER by Novacyt UK Holdings Limited (a wholly-owned subsidiary of Novacyt S.A.) for Yourgene Health plc to be effected by means of a Scheme of Arrangement under Part